ライフサイエンスコーパス: Bifidobacterium

1 albeit with an especially high abundance of Bifidobacterium.

2 iotas, particularly enriched in Bombella and Bifidobacterium.

3 association between rs4988235 (MCM6/LCT) and Bifidobacterium.

4 s with qPCR showed a significant increase in Bifidobacterium.

5 ersification of sugar uptake proteins within Bifidobacterium.

6 tobacillus + Lactococcus (6 x 10(10) CFU/g), Bifidobacterium (1 x 10(10)/g), Propionibacterium (3 x 1

7 adding 3 or 7 g ITF to snack bars increased Bifidobacterium, a beneficial member of the gut microbia

8 a gene-diet interaction in the regulation of Bifidobacterium abundance.

9 d the growth of beneficial bacteria, such as Bifidobacterium (Actinobacteria) and Akkermansia (Verruc

10 Bifidobacterium adolescentis (41.73 %) was remarkable fo

11 ial markers: Bacteroidales HF183 (HF183) and Bifidobacterium adolescentis (BifAd); one viral marker:

12 (p(adj) < 0.001), while HH-NR showed higher Bifidobacterium adolescentis and Bacteroides eggerthii (

13 e two most dominant Bifidobacterium species, Bifidobacterium adolescentis and Bifidobacterium pseudoc

14 Bifidobacterium adolescentis and other beneficial bacter

15 ned with the GH5 enzyme stimulated growth of Bifidobacterium adolescentis but not of Lactobacillus br

16 teriaceae; genus Bifidobacterium and species Bifidobacterium adolescentis exert causal effects leadin

17 arch yielded a candidate 20beta-HSDH gene in Bifidobacterium adolescentis strain L2-32.

18 AP diet had significantly lower abundance of Bifidobacterium adolescentis, Bifidobacterium longum, an

19 dren with FPIES contained significantly less Bifidobacterium adolescentis, but more pathobionts, incl

20 an symbiont bacterial species, in particular Bifidobacterium adolescentis, that could, alone, induce

21 erol further, and increased the abundance of Bifidobacterium adolescentis.

22 Depletion of Bifidobacterium after prolonged labor was a secondary pa

23 abundance of certain bacteria (for example, Bifidobacterium, Akkermansia and Faecalibacterium), high

24 Oral administration of Bifidobacterium alone improved tumor control to the same

25 ls of Bartonella (denoted as uncultured) and Bifidobacterium, along with an unexpected presence of Wo

26 ment of early microbiota and to increase the Bifidobacterium amounts as observed in human-milk-fed in

27 cteroides, Roseburia-Eubacterium rectale and Bifidobacterium and an increase of Enterobacteriaceae, D

28 Comparison to the Bifidobacterium and B. breve core genomes highlights a h

29 Bifidobacterium and Bacilli species exhibited significan

30 Evidence from measurements of Bifidobacterium and bacterial diversity analysis suggest

31 ween microbial traits and disease (including Bifidobacterium and body composition); however, in the a

32 Certain Bifidobacterium and Bombilactobacillus species were stro

33 cus and Oscillospira and lower abundances of Bifidobacterium and Collinsella in HIV-infected women co

34 cus and Oscillospira and lower abundances of Bifidobacterium and Collinsella in women with HIV than i

35 that the relative abundance of Allobaculum, Bifidobacterium and Coriobacteriaceae taxa associated wi

36 ignificant increases in species of the genus Bifidobacterium and decreases in Bacteroides vulgatus wi

37 of the allergic 8-year-olds was enriched in Bifidobacterium and depleted of Lactobacillus, Enterococ

38 These include absence of Bifidobacterium and differences in microbial composition

39 ccharide utilization, and parallel decreased Bifidobacterium and Eubacterium spp, and fermentative pa

40 ived the synbiotic had higher proportions of Bifidobacterium and Faecalibacterium species, and reduct

41 An early-life microbiota with increased Bifidobacterium and human milk oligosaccharide (HMO) uti

42 against select gut commensals (Bacteroides, Bifidobacterium and Lactobacillus species), and were non

43 support a relationship between abundances of Bifidobacterium and of putative pathogens or a significa

44 Bifidobacterium and Prevotella amounts were significantl

45 Chronic RW consumption increases Bifidobacterium and Prevotella amounts, which may have b

46 obiota taxa family Bifidobacteriaceae; genus Bifidobacterium and species Bifidobacterium adolescentis

47 We replicate an association between Bifidobacterium and the lactase (LCT) gene locus and ide

48 At a strain-resolved level, Bifidobacterium and their hosts exhibit strong co-phylog

49 nd Turicibacteraceae), Actinobacteria (genus Bifidobacterium) and Bacteroidetes (i.a.

50 ly isolated include Aerococcus, Gardnerella, Bifidobacterium, and Actinobaculum.

51 , such as Bacteroides, Akkermansia, Blautia, Bifidobacterium, and Enterococcus, were associated with

52 tinobacteria increased with trend for higher Bifidobacterium, and Proteobacteria decrease accounted f

53 y was identified to be mainly contributed by Bifidobacterium, and this functional capacity was lower

54 cycles of Lactobacillus acidophilus La-5 and Bifidobacterium animalis BB12.

55 d milk product containing dairy starters and Bifidobacterium animalis potentiates colonic short chain

56 ombination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB-12 (total cell

57 ombination of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB-12 did not sign

58 Escherichia coli, Lactobacillus acidophilus, Bifidobacterium animalis subsp lactis, Faecalibacterium

59 The FMPP contained Bifidobacterium animalis subsp Lactis, Streptococcus the

60 s' mating date, Groups CP and PEP were given Bifidobacterium animalis subsp.

61 Bifidobacterium animalis subsp.

62 and EP-HN019, 1 mL of suspensions containing Bifidobacterium animalis subsp. lactis (B. lactis) HN019

63 ei subsp. paracasei (L. casei 01); QB - with Bifidobacterium animalis subsp. lactis (BB 12); and QC,

64 We present the complete genomes of Bifidobacterium animalis subsp. lactis B420 and Bi-07.

65 comprising, Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12 and Propion

66 assette (ABC) transporter from the probiotic Bifidobacterium animalis subsp. lactis Bl-04 binds alpha

67 he first beta-(1,6)/(1,3)-galactosidase from Bifidobacterium animalis subsp. lactis Bl-04.

68 consumed a fermented milk product containing Bifidobacterium animalis subsp. lactis DN-173 010 strain

69 ct of 4-week use of yogurt supplemented with Bifidobacterium animalis subsp. lactis DN-173010 versus

70 robiotic fermented milks were produced using Bifidobacterium animalis subsp. lactis HN019 in co-cultu

71 of the study was to investigate the role of Bifidobacterium animalis subsp. lactis in preventing nos

72 Comparative genomic analysis of two Bifidobacterium animalis subsp. lactis strains revealed

73 ysiological responses of two fully sequenced Bifidobacterium animalis subsp. lactis strains, BL-04 an

74 to-oligosaccharides, 4 g twice per day, plus Bifidobacterium animalis subspecies lactis BB-12; n = 55

75 illus spp and 1 or more Bifidobacterium spp, Bifidobacterium animalis subspecies lactis, Lactobacillu

76 sei IMVB-7280, Bifidobacterium animalis VKL, Bifidobacterium animalis VKB) at a dose of 50 mg/kg (5 x

77 trains (2:1:1 Lactobacillus casei IMVB-7280, Bifidobacterium animalis VKL, Bifidobacterium animalis V

78 bacillus reuteri, Lactobacillus casei GG, or Bifidobacterium animalis) in the gastrointestinal tracts

79 acillus reuteri, Lactobacillus casei GG, and Bifidobacterium animalis) to colonize, infect, stimulate

80 quencing of the 16S ribosomal RNA identified Bifidobacterium as associated with the antitumor effects

81 hages that target the core microbiota member Bifidobacterium asteroides, but that exhibited different

82 er of Enterococcus, Prevotella, Bacteroides, Bifidobacterium, Bacteroides uniformis, Eggerthella lent

83 iven different probiotic products: Infloran (Bifidobacterium bifidum and Lactobacillus acidophilus) o

84 cillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum and Streptococcus faecium) in ca

85 2,313, Bifidobacterium longum BCMC(R) 02120, Bifidobacterium bifidum BCMC(R) 02290 and Bifidobacteriu

86 ether consuming Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and B. longum MM-2 compare

87 Bifidobacterium bifidum has emerged as a promising probi

88 n conducted until now, inferred pathways for Bifidobacterium bifidum include perchlorate reduction vi

89 Whole-genome transcription profiling of Bifidobacterium bifidum PRL2010, a strain isolated from

90 Bifidobacterium bifidum strain BB1 causes a strain-speci

91 sian infants commonly maintained a probiotic Bifidobacterium bifidum strain in infancy.

92 f Bifidobacterium longum subsp. infantis and Bifidobacterium bifidum using individual HMO, and compar

93 A multispecies probiotic consisting of Bifidobacterium bifidum W23, Bifidobacterium lactis W51,

94 tal of 10(7) colony-forming units (CFU)/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidoba

95 obacillus rhamnosum, Bifidobacterium longum, Bifidobacterium bifidum, Saccharomyces boulardi, Sacchar

96 rmentation of okara(ET) by a pure culture of Bifidobacterium bifidus was mainly represented by acetic

97 and favoring growth of the beneficial genera Bifidobacterium (bread crust, pilsner and black beers, c

98 igned (1:1) to groups given oral capsules of Bifidobacterium breve (Bif195) (>=5 x 10(10) colony-form

99 In comparison, Bifidobacterium breve ATCC 15700 showed significantly le

100 d to test the effectiveness of the probiotic Bifidobacterium breve BBG-001 to reduce necrotising ente

101 We hypothesized that Bifidobacterium breve CECT7263 (BFM) would attenuate hyp

102 cted for cow's milk CLA/CLNA-enrichment with Bifidobacterium breve DSM 20091.

103 g fed with a diet containing scGOS/lcFOS and Bifidobacterium breve M-16V (GF/Bb) or a control diet.

104 ism by which scGOS/lcFOS in combination with Bifidobacterium breve M-16V protects against acute aller

105 supplementation for 8 wk with human-derived Bifidobacterium breve strains on fat distribution and co

106 Here we show that Bifidobacterium breve UCC2003 produces a cell surface-as

107 5 transposon mutant library of the commensal Bifidobacterium breve UCC2003 that was further character

108 pathway or bifid shunt) of the gut commensal Bifidobacterium breve UCC2003.

109 Bifidobacterium breve, a prominent member of infant micr

110 ng units (CFU)/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum

111 d composition and cluster 2 was dominated by Bifidobacterium breve, with both clusters observed in ba

112 otics had a significantly lower abundance of Bifidobacterium (by 55%; 95% CI, 43% to 87%; P = .006; a

113 nt, probiotic, Lactobacillus, Saccharomyces, Bifidobacterium, Candida, gastrointestinal- system, vagi

114 hma was associated with lower RA of B breve, Bifidobacterium catenulatum, Prevotella copri, Veilloell

115 Culture of bacteria belonging to the Bifidobacterium, Clostridium and Enterococcus genera pro

116 Veillonellaceae sp. HOT 155 (p < 0.01), and Bifidobacterium Cluster 1 (p = 0.11), and by qPCR, Strep

117 antitative perspective of the early-life gut Bifidobacterium colonization and shows how factors such

118 Bifidobacterium colonization restores intestinal and pul

119 tnatal day 4 (P4), conventionalized mice and Bifidobacterium-colonized mice exhibited decreased expre

120 robiota was dominated with Lactobacillus and Bifidobacterium communities among 36 women (80%) in the

121 ge while Actinobacteriota species, including Bifidobacterium, decreased.

122 elative taxonomic quantitative abundances of Bifidobacterium dentium and other species that have been

123 myces odontolyticus, Actinomyces meyeri, and Bifidobacterium dentium were all positive for so-called

124 ers into three types: Escherichia-dominated, Bifidobacterium-dominated, and a diverse, pathogen-preva

125 Bifidobacterium-driven microbiome maturation was also li

126 teria and/or butyrate producers-Akkermansia, Bifidobacterium, Eubacterium halii, unassigned Lachnospi

127 nteract with host immunity, we observed that Bifidobacterium facilitates local anti-CD47 immunotherap

128 Relative abundance of lactose-fermenting Bifidobacterium, Faecalibacterium, and Lactobacillus wer

129 Instead, Bifidobacterium, Gardnerella, Prevotella, Pseudomonas, o

130 ia, Dialister, Anaerococcus, Prevotella, and Bifidobacterium/Gardnerella.

131 association of a functional LCT SNP with the Bifidobacterium genus (P = 3.45 x 10(-8)) and provide ev

132 tably an increased relative abundance of the Bifidobacterium genus from (mean +/- SEM) 5.3% +/- 5.9%

133 rvention were an increased proportion of the Bifidobacterium genus, a decreased level of unclassified

134 enetic variability of (pro)phages within the Bifidobacterium genus, a dominant bacterial group of the

135 It is noteworthy that the Bifidobacterium genus, which is commonly used in probiot

136 Several species of Bifidobacterium have been shown to utilize HMOs by conse

137 s, Enterobacteriaceae, Escherichia coli, and Bifidobacterium in apple cultured faeces tended to resem

138 re increased abundances of Lactobacillus and Bifidobacterium in resistant mice.

139 utes, increased Bacteroidetes, and decreased Bifidobacterium in the microbiome of AD participants.

140 rain transfer involving members of the genus Bifidobacterium, including species/strains present at lo

141 Most of the members of the genus Bifidobacterium, including the related organism Alloscar

142 Newborn rat pups were given Bifidobacterium infantis (10(9) organisms per animal dai

143 out by giving Lactobacillus acidophilus and Bifidobacterium infantis (LB) to pregnant C57/BL6J mice

144 ulating material for two probiotic bacteria: Bifidobacterium infantis and Lactobacillus plantarum by

145 0, Bifidobacterium bifidum BCMC(R) 02290 and Bifidobacterium infantis BCMC(R) 02129 (n = 27).

146 e changes are prevented by administration of Bifidobacterium infantis, a probiotic known to decrease

147 ed the aggregation of a rod-shaped bacteria, Bifidobacterium infantis, during capillary electrophores

148 reported for a number of organisms including Bifidobacterium infantis.

149 s interactions with other microbes including Bifidobacterium infantis.

150 Bifidobacterium is a commensal bacterial genus ubiquitou

151 linical significance of 15 A. omnicolens and Bifidobacterium isolates identified by 16S rRNA gene seq

152 current study, we isolated a novel strain of Bifidobacterium kashiwanohense, named APCKJ1, from the f

153 movements/wk), and this was significant for Bifidobacterium lactis (WMD: 1.5 bowel movements/wk; 95%

154 igher count of Lactobacillus acidophilus and Bifidobacterium lactis and resulted in a higher producti

155 x 10(7) colony-forming units (CFU)/g each of Bifidobacterium lactis and Streptococcus thermophilus, f

156 (Lactobacillus rhamnosus strain GG [LGG] and Bifidobacterium lactis Bb12 [Bb12]), mimicking gut comme

157 with Lactobacillus paracasei CNCM I-2116 or Bifidobacterium lactis CNCM I-3446 had a treatment effec

158 er all 28 days, the cheese supplemented with Bifidobacterium lactis in its isolated form showed the h

159 probiotics, Lactococcus lactis NCC 2287 and Bifidobacterium lactis NCC 2818, were tested in a murine

160 biota co-metabolism were further modified by Bifidobacterium lactis NCC2818 supplementation, although

161 10(6) cfu/g of Lactobacillus acidophilus and Bifidobacterium lactis strains or 300 g/d plain yogurt d

162 c consisting of Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Lactobacillus acidophilus W3

163 Systemic administration of Bifidobacterium leads to its accumulation within the tum

164 UDP-glucose 4-epimerase (GalE) from Bifidobacterium longum (bGalE) catalyzes epimerization r

165 of a MINPP from the Gram-positive bacterium Bifidobacterium longum (BlMINPP).

166 Bifidobacterium longum 1714 has been shown to influence

167 nd that, when orally administered to humans, Bifidobacterium longum AH1206 stably persists in the gut

168 e we investigate how two commensal bacteria, Bifidobacterium longum and Bacteroides fragilis, represe

169 ciferases, and two bacterial hosts, Gram (+) Bifidobacterium longum and Gram (-) Escherichia coli, we

170 ning Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536 on plasma lipids, lipid per

171 1, Lactobacillus casei subsp BCMC(R) 12,313, Bifidobacterium longum BCMC(R) 02120, Bifidobacterium bi

172 receive (1) Lactobacillus rhamnosus LPR and Bifidobacterium longum BL999 (LPR+BL999), (2) L paracase

173 eloped to quantify the consumption of FOS by Bifidobacterium longum bv. infantis using a calibration

174 A distinct Bifidobacterium longum clade expanded with introduction

175 te genome sequence of an intestinal isolate, Bifidobacterium longum DJO10A that was minimally culture

176 Viability of Bifidobacterium longum in soymilk added with polysacchar

177 actobacillus delbrueckii ssp. bulgaricus and Bifidobacterium longum in soymilk supplemented with tea

178 of AXOS in a complex fermentation medium by Bifidobacterium longum LMG 11047.

179 prospective study to evaluate the effects of Bifidobacterium longum NCC3001 (BL) on anxiety and depre

180 In this study, the mechanisms through which Bifidobacterium longum strain BB68 affects the longevity

181 l elucidation of the major polar lipids from Bifidobacterium longum subs. infantis.

182 Bifidobacterium longum subsp.

183 Crucially, the beneficial effects of Bifidobacterium longum subsp.

184 Here we screened infant-gut isolates of Bifidobacterium longum subsp. infantis and Bifidobacteri

185 d the utility of a beta-1,3-galactosidase in Bifidobacterium longum subsp. infantis ATCC 15697 (B. in

186 Accordingly, the complete genome sequence of Bifidobacterium longum subsp. infantis ATCC15697 reflect

187 tabolism of HMO 2'-fucosyllactose (2'-FL) in Bifidobacterium longum subsp. infantis Bi-26.

188 n the mode-of-action of 2'-FL utilization by Bifidobacterium longum subsp. infantis Bi-26.

189 Bifidobacterium longum subsp. infantis efficiently consu

190 llel glycoprofiling documented that numerous Bifidobacterium longum subsp. infantis strains preferent

191 rsity; only 10% of Finnish infants harboured Bifidobacterium longum subsp. infantis, a subspecies spe

192 icular infant-associated commensals, such as Bifidobacterium longum subsp. infantis, consume neutral

193 In our hospital, we documented 2 cases of Bifidobacterium longum subspecies infantis bacteremia in

194 Bifidobacterium longum subspecies infantis is a prominen

195 The counts of Bifidobacterium longum were higher in samples (n = 17) f

196 r abundance of Bifidobacterium adolescentis, Bifidobacterium longum, and Faecalibacterium prausnitzii

197 idobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum subspecies infantis (i

198 illus acidophillus, Lactobacillus rhamnosum, Bifidobacterium longum, Bifidobacterium bifidum, Sacchar

199 erial strains, we selected 4 SCFA-producers (Bifidobacterium longum, Clostridium symbiosum, Faecaliba

200 accharide lacto-N-biose-binding protein from Bifidobacterium longum, indicating that the recognition

201 al species, Bacteroides thetaiotaomicron and Bifidobacterium longum.

202 sequence similarity to the O-glycosidase of Bifidobacterium longum.

203 n vaginally born babies and was dominated by Bifidobacterium longum.

204 iota is often colonized by two subspecies of Bifidobacterium longum: subsp. infantis (B. infantis) an

205 t role in caries initiation and that a novel Bifidobacterium may be a major pathogen in deep caries.

206 ferent beta-galactosides are observed within Bifidobacterium members, but the basis of these preferen

207 T cell dysfunction could be reversed with a Bifidobacterium metabolite, supporting a gut-lung immune

208 2 (positive loadings on Fusicatenibacter and Bifidobacterium; negative loadings on Bacteroides) was a

209 Lactobacillus and bifidobacterium numbers were linked with low CAI.

210 istration of probiotic bacteria of the genus Bifidobacterium on experimental periodontitis (EP) in ra

211 MOM infants contained increased abundance of Bifidobacterium (P = 0.02) and Bacteroides (P = 0.04), w

212 Accordingly, a Bifidobacterium pflB knockout showed diminished I3C gene

213 I3C or an engineered bacteria overexpressing Bifidobacterium pflB protected against ALF.

214 Local delivery of Bifidobacterium potently stimulates STING signaling and

215 igation was to develop baking products using Bifidobacterium pseudocatenulatum ATCC27919, a phytase p

216 he effect of a yoghurt supplement containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium

217 um species, Bifidobacterium adolescentis and Bifidobacterium pseudocatenulatum, and an increased abun

218 Enriched Bifidobacterium pseudocatenulatum, Megamonas hypermegale

219 Accordingly, a panel of species, including Bifidobacterium pseudocatenulatum, Roseburia spp. and Ak

220 ecies driving these differences converged on Bifidobacterium pseudolongum.

221 % +/- 7.6% to 10.4% +/- 9.6% was observed in Bifidobacterium relative abundance after the interventio

222 ia (rho = - 0.867, p = 0.001) in females and Bifidobacterium (rho = - 0.838, p = 0.009) and Bacteroid

223 sing cell numbers, Actinomyces gerencseriae, Bifidobacterium, S. mutans, Veillonella, S. salivarius,

224 trials (RCTs) of probiotics (Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococ

225 four species: A. omnicolens (five isolates), Bifidobacterium scardovii (four isolates), B. longum (tw

226 inal bacterial genera such as Lactobacillus, Bifidobacterium, Snodgrassella, and Gilliamella were det

227 as a Facklamia sp., Eubacterium tenue, and a Bifidobacterium sp.

228 ry, the quantity of Lactic Acid Bacteria and Bifidobacterium sp. increased concurrently during the co

229 acillus casei, L. reuteri, L. acidophilus, a Bifidobacterium sp., Lactococcus lactis, or a Bacillus s

230 arriage of eight signature infant-associated Bifidobacterium species (B. longum, B. breve, B. bifidum

231 in adequate relief of symptoms (P = .52) or Bifidobacterium species (P = .68).

232 s were adequate relief of symptoms and stool Bifidobacterium species abundance at 4 weeks.

233 mentation of GOS selectively increased fecal Bifidobacterium species abundance, but this did not prod

234 al sources associated with A. omnicolens and Bifidobacterium species and addresses identification pro

235 exhibited significantly lower abundances of Bifidobacterium species and Akkermansia muciniphilia.

236 linical significance of A. omnicolens and of Bifidobacterium species are unclear.

237 but not placebo, increased the abundance of Bifidobacterium species in feces by 5-fold (P = .009; q

238 Breast milk enhances the predominance of Bifidobacterium species in the infant gut, probably due

239 his, we have determined the ability of three Bifidobacterium species isolated from the faeces of newb

240 omparative genome sequence analysis of three Bifidobacterium species provided a core genome set of 1,

241 udy highlights two major strategies found in Bifidobacterium species to process HMO, and presents det

242 placebo (192 +/- 93) (P = .721) Abundance of Bifidobacterium species was lower in fecal samples from

243 e (containing multiple Lactobacillus and one Bifidobacterium species), or Gynophilus LP vaginal table

244 addition, a dearth of the two most dominant Bifidobacterium species, Bifidobacterium adolescentis an

245 e multistrain probiotic increased numbers of Bifidobacterium species, compared with placebo, and migh

246 ant microbiota consortium consisting of four Bifidobacterium species, or with a complex, conventional

247 es involved in immunity development, such as Bifidobacterium species, Sutturella wadsworthia, and Clo

248 rbor divergent microbiota, including various Bifidobacterium species, yet their evolutionary relation

249 ides-Porphyromonas-Prevotella group (BPP) to Bifidobacterium species.

250 predominance of beneficial Lactobacillus and Bifidobacterium species.

251 lyticum, Mycoplasma hominis, and Gardnerella/Bifidobacterium species.

252 of 1 or more Lactobacillus spp and 1 or more Bifidobacterium spp and Saccharomyces boulardii reduced

253 llus spp and Enterococcus spp, and 1 or more Bifidobacterium spp and Streptococcus salivarius subsp t

254 n had increased Prevotella spp and decreased Bifidobacterium spp relative to age-matched placebo-trea

255 of 1 or more Lactobacillus spp and 1 or more Bifidobacterium spp vs single- and other multiple-strain

256 re Lactobacillus species (spp) and 1 or more Bifidobacterium spp was the only intervention with moder

257 of 1 or more Lactobacillus spp and 1 or more Bifidobacterium spp, Bifidobacterium animalis subspecies

258 rectale (cluster XIVab), Bacteroidetes, and Bifidobacterium spp, but decreased segmented filamentous

259 ia in the developing gut, often dominated by Bifidobacterium spp.

260 daidzein) to equol in soymilk fermented with Bifidobacterium spp.

261 s a significant time-by-group interaction on Bifidobacterium spp. (P = 0.008) and Lactobacillus/Pedio

262 dysbiosis signatures included an increase in Bifidobacterium spp. after chronic sublethal exposure an

263 h Sulfatrim restored the level of intestinal Bifidobacterium spp. and Clostridium spp.

264 in a transient increase in the abundance of Bifidobacterium spp. and Clostridium spp. in fecal sampl

265 ere was a nonsignificant trend toward higher Bifidobacterium spp. in the Fe+GOS group (P = 0.099).

266 in reaction showed a significant increase in Bifidobacterium spp. in the OI group compared with contr

267 olysates did not generally support growth of Bifidobacterium spp. in vitro.

268 ase (p < 0.01) in the Lactobacillus spp. and Bifidobacterium spp. populations was observed during the

269 The ratio of BPP to Bifidobacterium spp. rRNA in infants randomly assigned t

270 ene analysis revealed that the population of Bifidobacterium spp. significantly decreased by fold cha

271 Coprobacillus spp., Mucispirillum spp., and Bifidobacterium spp. were reduced, while Prevotella spp.

272 abundance of taxa such as Roseburia spp. and Bifidobacterium spp., alongside more favorable metabolic

273 he first year of life, showing enrichment of Bifidobacterium spp., and reduction of Enterococcus and

274 sal bacterial communities (Bacteroides spp., Bifidobacterium spp., Clostridium leptum group, Enteroba

275 omoted growth of beneficial bacteria such as Bifidobacterium spp., Lactobacillus spp., Bacteroides ac

276 This Bifidobacterium strain contributed to myo-inositol hexak

277 y (VCE) to assess the efficacy of a specific Bifidobacterium strain in healthy volunteers exposed to

278 he-shelf probiotic preparations that include Bifidobacterium strains also drove intestinal Th17 cell

279 obacillus and mutans streptococci (MS), most Bifidobacterium strains and non-mutans streptococci (non

280 Besides infant age, Bifidobacterium strains and stool metabolites were the b

281 The potential of LAB and Bifidobacterium strains to produce functional soy drink

282 erm colonization (24 mo) of the supplemented Bifidobacterium strains was not detected.

283 c properties in vitro with Lactobacillus and Bifidobacterium strains.

284 same taxa prevalent in infant humans (e.g., Bifidobacterium, Streptococcus, and Bacteroides), and ch

285 Here, genome analyses of 47 representative Bifidobacterium (sub)species revealed the genes predicte

286 y was identified to be mainly contributed by Bifidobacterium; this functional capacity was lower in w

287 BW-administered mice also showed a lower Bifidobacterium to Akkermansia ratio pre-EAE induction w

288 By P20, both conventional and Bifidobacterium-treated mice exhibited normal synaptic d

289 Bifidobacterium was 2.6- to 5-fold lower in SF relative

290 roxy-hydrocinnamic acid, and betaine whereas Bifidobacterium was negatively associated with 5-hydroxy

291 aceae were increased in the HCC group, while Bifidobacterium was reduced.

292 Bifidobacterium was the most abundant genus in wild anim

293 Bifidobacterium was the only genus that increased signif

294 infant microbiomes increasingly have reduced Bifidobacterium, we examine early-life dysbiosis and int

295 ing Faecalibacterium prausnitzii), and genus Bifidobacterium were decreased in patients with IBS.

296 Akkermansia and Bifidobacterium were inversely correlated with calprotec

297 Bifidobacterium were less abundant than generally expect

298 With low-dose ITF, significant increases in Bifidobacterium were no longer present after correction

299 ducing bacteria of the genera Prevotella and Bifidobacterium, which increased fecal and systemic SCFA

300 creases in the abundances of Collinsella and Bifidobacterium, which were depleted in FMT responders b

301 we investigated the basis of degradation in Bifidobacterium wkB204, a strain that fully degrades amy